期刊文献+

自泌性白细胞介素6在人脑胶质瘤发病中的作用 被引量:1

Role of interleukin-6in the occurring and developing of human gliomas
下载PDF
导出
摘要 目的:探讨原代培养的人脑胶质瘤细胞是否分泌及表达白细胞介素6(Interleukin-6,IL-6),以及IL-6在人脑胶质瘤发病中的作用。方法:采用手术中直接获得的人脑胶质瘤组织,进行胶质瘤细胞的原代培养,并分别采用四唑盐比色分析法(MTT)及逆转录聚合酶链反应(RT-PCR)方法测定人脑胶质瘤细胞中IL-6的分泌及表达;再分别采用IL-6及IL-6单抗处理脑胶质瘤细胞。结果:①原代培养的人脑胶质瘤细胞可自发分泌IL-6,而正常人脑胶质细胞则无IL-6的分泌;②30例人脑胶质瘤标本中有25例表达IL-6基因,且其表达量与脑胶质瘤的恶性程度呈正相关关系;③IL-6能刺激脑胶质瘤细胞的增殖,而IL-6单抗则能抑制脑胶质瘤细胞的增殖。结论:IL-6在人脑胶质瘤中的异常分泌及表达可能是参与和维持脑胶质瘤恶性增殖的原因之一。 Objective:To explore the secretion and expression of interleukin-6(IL-6)in isolated fresh glioma cells,and to confirm the role of IL-6in the occurring and developing of human gliomas.Methods:The fresh isolated human glioma cells were cultured at different time,MTT and RT-PCR meth-ods were used to detect the biological activity of IL-6and the expression of IL-6gene in human glioma cells.Different concentrations of IL-6and IL-6McAb were used to act on fresh isolated human glioma cells.Results:①The isolated fresh human glioma cells secreted IL-6spontaneously without any stimulants.②The expression of IL-6gene was detectable in25tumor specimens(83.3%),and malignant tumors of high grade expressed significantly larger amount of IL-6gene compared to those of low grade.③IL-6stim-ulated but IL-6McAb suppressed the proliferation of human glioma cells.Conclusion:The abnormal se-cretion and expression of IL-6may play an important role in sustaining the malignant proliferation of hu-man gliomas.
出处 《山东大学学报(医学版)》 CAS 2003年第4期394-396,共3页 Journal of Shandong University:Health Sciences
基金 山东省医药卫生"九五"攻关课题(鲁卫攻关08号)
关键词 胶质瘤细胞 白细胞介素-6 分泌 基因表达 逆转录聚合酶链反应 Human glioma cells Interleukin-6 Secretion Gene expression Reverse transcriptase polymerase chain reaction
  • 相关文献

参考文献7

  • 1田志刚,张建华.MTT法在检测细胞因子与细胞毒效应中的应用[J].中国肿瘤生物治疗杂志,1994,1(1):74-79. 被引量:20
  • 2Chromczynski P, Saccchi N. Single-step method of RNA isolation by acid quanidinium thiocyanate-phenol-chloroform extration[J]. Anal Biochem, 1987,162:156.
  • 3Yasukawa K, Hirano T, Watanabe Y,et al. Structure and expression of human BSF2/IL-6 gene[J]. EMBOJ, 1987,6(10):2939.
  • 4Van Meir E, Sawamura Y, Diserens AC, et al. Human glioblastoma cells release IL-6 in vivo and in vitro [J]. Cancer Res, 199035(20):6683.
  • 5Kishimoto T. The biology of interleukin-6 [J]. Blood,1989,74:1.
  • 6Giometto B, Bozza F, Faresin F, et al. Immune infiltrates and cytokines in gliomas[J]. Acta Neurochir Wien, 1996,138(1):50.
  • 7Ogata A, Nishimoto N, Yoshizaki K. Advances in interleukin-6 therapy[J]. Rinsho Byori, 1999,47(4):321.

二级参考文献8

共引文献19

同被引文献14

  • 1Rolhion C,Penault-Llorca F,Kemeny JL,et al.Interleukin-6 overexpression as a marker of malignancy in human gliomas[J].J Neurosurg,2001,94(1):97-101
  • 2Goswami S,Gupta A,Sharma SK.Interleukin-6-mediated autocrine growth promotion in human glioblastoma multiforme cell line U87MG[J].J Neurochem,1998,71(5):1837-1845
  • 3Oshima M,Azuma H,Suzutani T,et al.Direct and mononuclear cell mediated effects on interleukin 6 production by glioma cells in infection with herpes simplex virus type 1[J].J Med Virol,2001,63(3):252-258
  • 4Matsukado K,Inamura T,Nakano S,et al.Enhanced tumor uptake of carboplatin and survival in glioma-bearing rats by intracarotid infusion of bradykinin analog,RMP-7[J].Neurosurgery,1996,39(1):125-134
  • 5Bartus RT,Elliott P,Hayward N,et al.Permeability of the blood brain barrier by the bradykinin agonist,RMP-7:evidence for a sensitive,auto-regulated,receptor-mediated system[J].Immunopharmacology,1996,33 (1-3):270-278
  • 6Maher EA,Furnari FB,Bachoo RM,et al.Malignant glioma:genetics and biology of a grave matter[J].Genes Dev,2001,15(11):1311-1333
  • 7Chang CY,Li MC,Liao SL,et al.Prognostic and clinical implication of IL-6 expression in glioblastoma multiforme[J].J Clin Neurosci,2005,12(8):930-933
  • 8Emerich DF,Snodgrass P,Dean RL,et al.Bradykinin modulation of tumor vasculature:Ⅰ.Activation of B2 receptors increases delivery of chemotherapeutic agents into solid peripheral tumors,enhancing their efficacy[J].J Pharmacol Exp Ther,2001,296(2):623 -631
  • 9Emerich DF,Dean RL,Snodgrass P,et al.Bradykinin modulation of tumor vasculature:Ⅱ.activation of nitric oxide and phospholipase A2/prostaglandin signaling pathways synergistically modifies vascular physiology and morphology to enhance delivery of chemotherapeutic agents to tumors[J].J Pharmacol Exp Ther,2001,296(2):632 - 641
  • 10Koyama S,Sato E,Nomura H,et al.Bradykinin stimulates type Ⅱ alveolar cells to release neutrophll and monocyte chemotactic activity and inflammatory cytokines[J].Am J Pathol,1998,153(6):1885-1893

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部